# AI in Genomics * **Definition:** The application of artificial intelligence techniques, including machine learning and deep learning, to analyze genomic data for insights into genetic variations, disease mechanisms, and personalized medicine, enhancing the understanding of complex biological systems and improving healthcare outcomes. * **Taxonomy:** CTO Topics / AI in Genomics ## News * Selected news on the topic of **AI in Genomics**, for healthcare technology leaders * 28.4K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 3/11/2025 | [**Equipping Healthcare Professionals for the AI-Powered Healthcare Revolution: Lessons ... - Medium**](https://medium.com/@alexglee/equipping-healthcare-professionals-for-the-ai-powered-healthcare-revolution-lessons-from-harvard-e8f83dd3df8b) | [[Medium]] | | 1/13/2025 | [**Spatial Genomics & Transcriptomics Market to Hit USD 995.7 Million by 2029 with 12.4AGR**](https://www.prnewswire.com/news-releases/spatial-genomics--transcriptomics-market-to-hit-usd-995-7-million-by-2029-with-12-4-cagr--marketsandmarkets-302348988.html) | [[PR Newswire]] | | 1/9/2025 | [**J.P. Morgan Healthcare Conference 2025: Genomics Announces Dr Jose-Carlos Gutierrez-Ramos as New Board Member to Accelerate Global Expansion and Life Sciences R&D Growth**](https://www.prnewswire.com/news-releases/jp-morgan-healthcare-conference-2025-genomics-announces-dr-jose-carlos-gutierrez-ramos-as-new-board-member-to-accelerate-global-expansion-and-life-sciences-rd-growth-302346244.html) | [[PR Newswire]] | | 1/9/2025 | [**In 2024, Complete Genomics expanded U.S. manufacturing and technology capabilities toward a diversified, reliable supply chain for its flexible and cost-effective NGS solutions**](https://www.prnewswire.com/news-releases/in-2024-complete-genomics-expanded-us-manufacturing-and-technology-capabilities-toward-a-diversified-reliable-supply-chain-for-its-flexible-and-cost-effective-ngs-solutions-302347290.html) | [[PR Newswire]] | | 1/9/2025 | [**In 2024, Complete Genomics expanded U.S. manufacturing and technology capabilities ...**](https://finance.yahoo.com/news/2024-complete-genomics-expanded-u-174300590.html) | [[Yahoo Finance]] | | 1/9/2025 | [**J.P. Morgan Healthcare Conference 2025: Genomics Announces Dr Jose-Carlos Gutierrez ...**](https://www.morningstar.com/news/pr-newswire/20250109la92113/jp-morgan-healthcare-conference-2025-genomics-announces-dr-jose-carlos-gutirrez-ramos-as-new-board-member-to-accelerate-global-expansion-and-life-sciences-rd-growth) | [[Morningstar]] | | 1/2/2025 | [**10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference**](https://www.prnewswire.com/news-releases/10x-genomics-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302340408.html) | [[PR Newswire]] | | 12/31/2024 | [**Global Nutrigenomics Industry to Reach USD 2,342.1 Million by 2034, Pioneering Nutrition ...**](https://www.morningstar.com/news/accesswire/961984msn/global-nutrigenomics-industry-to-reach-usd-23421-million-by-2034-pioneering-nutrition-and-health-advances-future-market-insights-inc) | [[Morningstar]] | | 12/31/2024 | [**Global Nutrigenomics Industry to Reach USD 2,342.1 Million by 2034, Pioneering Nutrition ...**](https://finance.yahoo.com/news/global-nutrigenomics-industry-reach-usd-080000828.html) | [[Yahoo Finance]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/23/2024 | [**Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share**](https://finance.yahoo.com/news/singular-genomics-enters-agreement-acquired-133000209.html) | [[Yahoo Finance]] | | 12/3/2024 | [**Aventa Genomics Receives Favorable Pricing Determination from Centers for Medicare and Medicaid Services**](http://www.businesswire.com/news/home/20241203858453/en/Aventa-Genomics-Receives-Favorable-Pricing-Determination-from-Centers-for-Medicare-and-Medicaid-Services/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/2/2024 | [**Large language models could help automate functional genomics research**](https://www.news-medical.net/news/20241202/Large-language-models-could-help-automate-functional-genomics-research.aspx) | [[News Medical Net]] | | 11/25/2024 | [**Digi-Tech Pharma & AI Conference 2025: AI and Genomics Take Center Stage ... - Business Wire**](https://www.businesswire.com/multimedia/houstonmedicine/20241125500751/en/5752647/Digi-Tech-Pharma-AI-Conference-2025-AI-and-Genomics-Take-Center-Stage-London-United-Kingdom---May-28-29-2025---ResearchAndMarkets.com) | [[Business Wire]] | | 11/19/2024 | [**Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now**](https://finance.yahoo.com/news/exact-sciences-corporation-exas-among-235759324.html) | [[Yahoo Finance]] | | 11/14/2024 | [**Bumrungrad International Hospital Partners with Golden Helix to Advance Genomics for Cancer and Hereditary Disease Initiatives**](https://www.prnewswire.com/news-releases/bumrungrad-international-hospital-partners-with-golden-helix-to-advance-genomics-for-cancer-and-hereditary-disease-initiatives-302304751.html) | [[PR Newswire]] | | 11/13/2024 | [**Genomics Market to Hit USD 66.85 Billion by 2029 with 9.4AGR - MarketsandMarkets™**](https://www.prnewswire.com/news-releases/genomics-market-to-hit-usd-66-85-billion-by-2029-with-9-4-cagr--marketsandmarkets-302303803.html) | [[PR Newswire]] | | 10/22/2024 | [**PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program**](https://markets.businessinsider.com/news/stocks/pacbio-onso-short-read-sequencing-instrument-joins-10x-genomics-compatible-partner-program-1033870667) | [[Business Insider Markets]] | | 9/30/2024 | [**Genomics plc Announces David Thornton as President - PR Newswire**](https://www.prnewswire.com/news-releases/genomics-plc-announces-david-thornton-as-president-302261076.html) | [[PR Newswire]] | | 9/10/2024 | [**Is it possible to automate agrigenomics?**](https://www.news-medical.net/whitepaper/20240910/Is-it-possible-to-automate-agrigenomics.aspx) | [[News Medical Net]] | | 7/29/2024 | [**Genomics Personalized Health Global Market 2024 To Reach $29.00 Billion By 2028 At ...**](https://tech.einnews.com/amp/pr_news/731200803/genomics-personalized-health-global-market-2024-to-reach-29-00-billion-by-2028-at-rate-of-16-1) | tech.einnews.com | | 6/25/2024 | [**Dante Genomics Generative AI GenomeChat Aims at Becoming Doctors' and Patients' Best Partner for Advanced Genomics Solutions**](https://www.bignewsnetwork.com/news/274432804/dante-genomics-generative-ai-genomechat-aims-at-becoming-doctors-and-patients-best-partner-for-advanced-genomics-solutions) | bignewsnetwork.com | | 6/25/2024 | [**Dante Genomics Generative AI GenomeChat Aims at Becoming Doctors' and Patients' Best Partner for Advanced Genomics Solutions**](https://markets.businessinsider.com/news/stocks/dante-genomics-generative-ai-genomechat-aims-at-becoming-doctors-and-patients-best-partner-for-advanced-genomics-solutions-1033503396) | [[Business Insider Markets]] | | 6/24/2024 | [**Global Genomics Industry Research 2024: Rising Adoption of Personalized Medicines and Gene Therapies - Forecasts to 2031 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20240624828195/en/Global-Genomics-Industry-Research-2024-Rising-Adoption-of-Personalized-Medicines-and-Gene-Therapies---Forecasts-to-2031---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **IBM**: A technology giant utilizing AI and machine learning to advance genomic research and drug discovery. - **Fabric Genomics**: A company specializing in genomic data analysis and interpretation, leveraging AI to enhance precision medicine. - **NVIDIA**: A key player in AI hardware and software, providing tools for genomic data processing and analysis. - **Dante Genomics**: A company integrating Generative AI into its Whole Genome platform to enhance genomic data accessibility. - **Helix**: A leader in population genomics and precision health, integrating AI for predictive analytics in healthcare. - **Microsoft**: A leading tech company applying AI solutions to genomics for improved healthcare outcomes. - **NeoGenomics**: A provider of cancer-focused genetic testing services, collaborating with ConcertAI to enhance research analytics. - **Complete Genomics**: A leader in high-throughput DNA sequencing technology, specializing in spatial multi-omics and advanced spatial transcriptomics. - **Mount Sinai Health System**: Launched the Hamilton and Amabel James Center for Artificial Intelligence and Human Health to integrate AI with data science and genomics. - **Genomics plc**: A company utilizing human genetics and machine learning for drug discovery, extending its partnership with Vertex Pharmaceuticals. - **10x Genomics**: A life science technology company developing products for single-cell and spatial biology solutions. - **Dovetail Genomics**: Provider of advanced genomic products and services, collaborating with AGRF to enhance genomic research in Australia and New Zealand. - **10x Genomics, Inc.**: Partnered with Beckman Coulter Life Sciences to automate single-cell gene expression workflows. ### Partnerships and Collaborations - **Dante Genomics and Generative AI**: Integration of Generative AI into the Whole Genome platform to support human decision-making in genomics. - **Complete Genomics and NVIDIA**: Formed strategic partnerships to improve genomic sequencing analysis and expand product offerings. - **ConcertAI and NeoGenomics**: They launched CTO-H, a software-as-a-service solution that provides extensive data on hematological diseases to improve clinical trial design. - **10x Genomics and Garvan Institute**: Collaboration on the TenK10K project to map human cells and uncover genomic fingerprints associated with diseases. - **Fabric Genomics and Intermountain Children's Health**: Collaborating to analyze whole genomes of pediatric patients to expedite genetic disease diagnosis. - **Illumina and LGC Biosearch Technologies**: A strategic partnership to enhance genomics applications in agriculture, particularly in the Asia-Pacific and Latin America regions. - **PACB and Berry Genomics**: An early access agreement to develop targeted assays for genomic testing in China. - **Dovetail Genomics and AGRF**: A strategic partnership to enhance genomic research and innovation across Australia and New Zealand. - **ACT Genomics and LSI Medience Corporation**: Collaboration to advance personalized medicine in the Japanese market. - **Ultima Genomics and Thermo Fisher Scientific**: Collaborating on the UK Biobank's protein study to analyze protein markers for disease progression. - **ERS Genomics Limited and Medicines Discovery Catapult**: Entered a non-exclusive CRISPR license agreement to enhance drug discovery processes. - **Revvity and Genomics England**: Expanding collaboration to enhance genomic initiatives, including the Generation Study for newborn screening. - **Labcorp and Ultima Genomics**: An expanded collaboration to utilize advanced sequencing technology for oncology testing. - **Complete Genomics and seqWell**: Partnering to enhance library preparation product offerings. - **Oxford Nanopore and UK Government**: Partnering to enhance genomics-driven healthcare innovation and improve patient care. - **Bumrungrad International Hospital and Golden Helix**: A multiyear agreement to enhance genomics initiatives focusing on cancer and hereditary disease diagnostics. - **Complete Genomics and Eurofins Clinical Enterprise**: This partnership aims to enhance access to high-quality sequencing services, utilizing Complete Genomics' DNBSEQ-T7 sequencer for various applications. - **Complete Genomics and STOmics**: Complete Genomics is the exclusive U.S. distributor of STOmics' Stereo-seq technology, enhancing spatial transcriptomics capabilities. - **Genoks and Velsera**: This partnership aims to improve cancer diagnostics and treatment accuracy in Turkey by integrating Velsera's Clinical Genomics Workspace. ### Innovations, Trends, and Initiatives - **AI-Driven Genomic Data Analysis**: Recent advancements in AI have revolutionized genomic data analysis, enabling faster and more precise genome sequencing and annotation. - **AI in Precision Medicine**: The integration of AI and machine learning into precision medicine software is transforming treatment pathways, particularly in cancer research, enabling personalized treatment based on genetic data. - **AI in Functional Genomics**: Researchers at UC San Diego demonstrated that large language models like GPT-4 can automate functional genomics research, achieving high accuracy in identifying gene functions. - **Generative AI in Genomics**: Dante Genomics emphasizes the importance of transparency in AI applications, likening it to autopilot systems in aviation. - **Generative AI Integration by Dante Genomics**: Enhancing genomic data accessibility and actionability through AI-powered narrative reports and improved diagnostic accuracy. - **Market Growth Projections**: The AI in Genomics Market is projected to grow from USD 1.15 billion in 2023 to USD 13.65 billion by 2029, with a CAGR of 51.03%. - **Emerging Technologies in Genomics**: Technological advancements, including AI and machine learning, are enhancing the processing of genetic data, leading to more precise health assessments and personalized nutrition solutions. - **Dante GenomeChat**: A GenAI platform designed to enhance clinical understanding of complex genomic data, providing personalized insights for doctors. - **CRISPR Gene Editing Enhancements**: AI applications in CRISPR technology are improving precision and reducing off-target effects in gene therapies. - **Spatial Genomics and Transcriptomics**: Projected market growth driven by increased acceptance in drug discovery and development. - **LLMs in Functional Genomics**: Research at UC San Diego shows LLMs like GPT-4 can automate gene function analysis, achieving 73% accuracy. - **AI-Powered Polygenic Risk Score by Helix**: A model predicting weight loss response to semaglutide, integrating co-morbid factors for personalized treatment. - **TenK10K Project**: A large-scale initiative by the Garvan Institute to map human cells and develop commercial tests for various diseases. - **Spatial Xcellerator Grant Program**: Launched by Complete Genomics to provide advanced spatial transcriptomics technologies for U.S. researchers. - **Nutrigenomics Market Growth**: Projected to grow significantly due to rising consumer demand for personalized health solutions based on genetic testing. - **Xenium Prime 5K Panel**: A new product from 10x Genomics that significantly increases gene plex while maintaining high performance metrics. - **NIH Grant to CUNY SPH**: A $5.2 million grant to develop open-source software and databases for cancer genomics. - **WHO Roadmap for Genomics**: The WHO Science Council released a roadmap to enhance access to genomic technologies, especially in low- and middle-income countries, emphasizing the need for policy frameworks and sustainable financing. - **LinkPrep™ Technology by Dovetail**: A technology aimed at improving the detection of structural variants in cancer genomics, supported by a $2 million SBIR grant. - **Next-Generation Sequencing (NGS)**: Technological innovations in NGS are improving accuracy and reducing costs, driving market growth. ### Challenges and Concerns - **AI Transparency**: Concerns about AI operating as a 'black box' in genomics, emphasizing the need for clarity in AI decision-making processes. - **Data Security and Standardization**: Ensuring data security and standardization in AI-driven genomic analysis and patient data management. - **Skilled Personnel Shortage**: There is a growing need for skilled professionals in genomics and AI, which poses a challenge for the industry. - **Ethical and Regulatory Challenges**: Navigating ethical concerns and regulatory frameworks as AI and genomics become more integrated in healthcare. - **Investment Hesitance**: Current market hesitance due to high interest rates, despite the potential for revolutionary growth in genomics driven by AI advancements. - **High Product Prices and Low Identification Rates**: Challenges in the neurogenomics market, including high costs and low rates of actionable mutation identification. - **Data Security**: Concerns over the privacy and security of genetic data are significant as genomic technologies advance. - **Shortage of Skilled Personnel**: A shortage of skilled professionals in genomics is impacting the industry's growth potential. - **Equitable Access to Genomics**: Despite advancements, there are significant disparities in the global distribution of genomic technologies, particularly in low- and middle-income countries. - **Ethical and Legal Concerns**: The integration of genomics into newborn screening raises issues regarding genetic information privacy and the implications of revealing such data. - **Ethical Considerations**: The potential misuse of genomic data and ensuring equitable access to genomic technologies are critical ethical concerns. - **Lack of Standardization**: The absence of standardized approaches in genomics poses challenges to market development. - **Data Security and Privacy**: Concerns regarding the security and privacy of genomic data are hindering market growth. - **Market Accessibility**: High costs of genetic testing may limit accessibility for consumers, particularly in low-resource settings. - **Implementation Barriers**: Challenges such as high implementation costs, interoperability issues, and the need for extensive training hinder the widespread adoption of precision medicine software. - **Data Privacy and Security**: The integration of digital technologies in healthcare raises concerns regarding the privacy and security of sensitive patient information, necessitating robust data protection measures. ## Related Topics [[AI in Biotechnology]]; [[AI in Precision Medicine]]; [[AI in Pathology]]; [[AI in Cancer Diagnostics]]; [[AI in Oncology]]; [[AI in Medical Diagnostics]]; [[AI in Medicine]]; [[AI in Drug Discovery]]; [[AI in Digital Pathology]]